UMIN ID: UMIN000056203
Registered date:19/11/2024
Safety and feasibility of virtual reality-guided rehabilitation for chemotherapy-induced peripheral neuropathy.
Basic Information
Recruitment status | Complete: follow-up continuing |
---|---|
Health condition(s) or Problem(s) studied | chemotherapy-induced peripheral neuropathy |
Date of first enrollment | 2024/03/10 |
Target sample size | 7 |
Countries of recruitment | Japan |
Study type | Observational |
Intervention(s) |
Outcome(s)
Primary Outcome | Number of VR-guided rehabilitation sessions and drop-out rates |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 18years-old |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | Individuals who have indicated their intention not to participate in the study. |
Related Information
Primary Sponsor | NHO Tokyo Medical Center |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Non |
Secondary ID(s) |
Contact
public contact | |
Name | Chieko Miyata |
Address | Higashigaoka 2-5-1, Meguro-ku, Tokyo Japan 152-8902 |
Telephone | 0334110111 |
kuma1mie2chibi3@yahoo.co.jp | |
Affiliation | NHO Tokyo Medical Center Palliative care medicine and Cancer rehabilitation |
scientific contact | |
Name | Chieko Miyata |
Address | Higashigaoka 2-5-1, Meguro-ku, Tokyo Japan |
Telephone | 0334110111 |
kuma1mie2chibi3@yahoo.co.jp | |
Affiliation | NHO Tokyo Medical Center Palliative care medicine and Caner rehabilitation |